BioNTech SE Postemployment Benefit Expense Defined Benefit Plans
BioNTech SE (BNTX) reported Postemployment Benefit Expense Defined Benefit Plans of EUR 4.70 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans · last filed 2026-03-10
| Period end | Postemployment Benefit Expense Defined Benefit Plans 12 month | Postemployment Benefit Expense Defined Benefit Plans 12 month as first filed |
|---|---|---|
| 2025-12-31 | 4.70M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 3.50M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 4.10M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 2.10M EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 1.20M EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | 800.00K EUR 20-F · filed 2023-03-27 | 761.00K EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 500.00K EUR 20-F/A · filed 2022-10-26 | 517.00K EUR 20-F · filed 2021-03-30 |
| 2018-12-31 | 324.00K EUR 20-F · filed 2021-03-30 |